Interspecies comparison and role of human cytochrome P450 and flavin-containing monooxygenase in hepatic metabolism of L-775,606, a potent 5-HT_1D receptor agonist

References

• AL-wmz, M., AYESH, R., MITCHELL, S. C., IDLE, J. R. and Swill, R. L., 1987, Trimethylaminuria (fish-odour syndrome)—an inborn error of oxidative metabolism. Lancet, 1, 634–635.
   Google Scholar
• CASHMAN, J. R., PARK, S. B., BERKIVIAN, C. E. and CASIEVIAN, L. E., 1995, Role of hepatic fiavin-containing monooxygenase 3 in drug and chemical metabolism in adult human. Chemico-Biological Interactions, 96, 33–46.
   PubMed Web of Science ®Google Scholar
• CASHMAN, J. R., B1, Y.-A, YOUIL, R., KNIGHT, M., FORREST, S. and TREACY, E., 1997, Human fiavin-containing monooxygenase form 3: cDNA expression of the enzymes containing amino acid substitutions observed in individuals with trimethylaminuria. Chemical Research in Toxicology, 10, 837–841.
   Google Scholar
• CHANG, T. K. H., GONZALEZ, F. J. and WAXIVIAN, D. J., 1994, Evaluation of triacetyloleandromycin, a-naphthoflavone and diethyldithiocarbamate as selective chemical probes for inhibition of human cytochromes P450. Archives of Biochemistry and Biophysics, 311, 437–442.
   Google Scholar
• DRAPER, A. J., MADAN, A. and PARKINSON, A., 1997, Inhibition of coumarin 7-hydroxylase activity in human liver microsomes. Archives of Biochemistry and Biophysics, 341, 47–61.
   PubMed Web of Science ®Google Scholar
• HADLEY, M. R., OLDHAM, H. G., CAMILLERI, P., DAMANI, L. A. and Hun, A. J., 1996, Species differences in the stereoselectivity of N-oxygenation of N-ethyl-N-methylaniline in vitro. Chirality, 8, 430110.
   Google Scholar
• HAMEL E., 1996,5-HT,D receptors: pharmacology and therapeutic potential. Serotonin, 1, 19–29.
   Google Scholar
• Hum, J.-Y., MIRANDA, C. L., BUR, D. R. and CHEFICE, P. R., 1998, Species differences in the hepatic microsomal enzyme metabolism of the pyrrolizidine alkaloids. Toxicology Letters, 99, 127–137.
   Google Scholar
• LANG, D. H., YEUNG C. K., PETER, R. M., IBARRA, C., GASSER, R., ITAGAKI, K., PHILPOT, R. M. and RETTI, A. E., 1998, Isoform specificity of triethylamine N-oxygenation by human fiavin-containing monooxygenase (FMO) and P450 enzymes. Biochemical Pharmacology, 56, 1005–1012.
   Google Scholar
• MACLEOD, A. M., STREET, L. J., REEVE, A. J., JELLEY, R. A., STERNFELD, F., BEER, M. S., STANTON, J. A., WATT, A. P., RATHBONE, D. and MATASSA, V. G., 1997, Selective, orally active 5-HT) receptor agonists as potential antimigraine agents. Journal Medicinal Chemistry, 40, 3501–3503.
   PubMedGoogle Scholar
• MINISALCO, A., LUNDAHL, J., REGARDH, C. G., EDGAR, B. and ERIKSSON, U. G., 1992, Inhibition of dihydropyridine metabolism in rat and human liver microsomes by fiavonoids found in grapefruit juice. Journal Pharmacology Experimental Therapeutics, 261, 1195–1199.
   PubMedGoogle Scholar
• NEWTON, D. J., WANG, R. W. and Lu, A. H. Y., 1995, Cytochrome P450 inhibitors: Evaluation of specificities in the in vitro metabolism of therapeutic agents by human liver microsomes. Drug Metabolism Disposition, 23, 154–158.
   PubMed Web of Science ®Google Scholar
• OVERBY, L. H., CARVER, G. C. and PHILPOT, R. M., 1997, Quantitation and kinetics properties of hepatic microsomal and recombinant fiavin-containing monooxygenases 3 and 5 from human. Chemico-Biological Interactions, 106, 29–45.
   PubMed Web of Science ®Google Scholar
• PLOSICER, G. L. and McTAvisx, D., 1994, A reappraisal of its pharmacology and therapeutic efficacy in the acute treatment of migraine and cluster headache. Drugs, 47, 622–651.
   PubMedGoogle Scholar
• PRUEKSARITANONT, T., GORHAM, L. M., MA, B., Liu, L., Yu, X., ZHAO, J. J., SLAUGHTER, D. E., ARISON B. H. and VYAS, K. P., 1997, In vitro metabolism of simvastatin in human: identification of metabolizing enzymes and effect of the drug on hepatic P450. Drug Metabolism Disposition, 25, 1191–1199.
   Google Scholar
• RAHMAN, A., KORZEKWA, K. R., GROGAN, J., GONZALEZ, F. J. and HARRIS, J. W., 1994, Selective biotransformation of taxol to 6a-hydroxytaxol by human cytochrome P450 2C8. Cancer Research, 54, 5543–5546.
   PubMed Web of Science ®Google Scholar
• RIPP, S. L., ITAGAKI, K., PHILPOT, R. M. and ELFARRA, A. A., 1999, Species and sex differences in the expression of fiavin-containing monooxygenase form 3 in liver and kidney microsomes. Drug Metabolism Disposition, 27, 46–52.
   PubMed Web of Science ®Google Scholar
• SHIMADA, T., YAMAZAKI, H., MimuRA, M., INui, Y. and GUENGERICH, F. P., 1994, Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: Studies with liver microsomes of 30 Japanese and 30 Caucasians. Journal of Pharmacology and Experimental Therapeutics, 270, 414–423.
   PubMed Web of Science ®Google Scholar
• THUMMEL, K. E. and WILKINSON, G. R., 1998, In vitro and in vivo drug interactions involving human CYP3A. Annual Review Pharmacology and Toxicology, 38, 389–430.
   PubMed Web of Science ®Google Scholar
• TUGNAIT, M., HAWES, E. M., McKAY, G., RETTIE, A. E., HAWING, R. L. and MIDHA, K. K., 1997, N-oxygenation of clozapine by fiavin-containing monooxygenase. Drug Metabolism Disposition, 25, 524–527.
   PubMed Web of Science ®Google Scholar
• WIENICERS, L. C., WURDEN, C. J., STORCH, E., KUNZE, K. L., RETTTE, A. E. and TRAGER, W. F., 1996, Formation of R-8-hydroxywarfarn in human liver microsomes—a new metabolic marker for the (S)-mephenytoin hydroxylase, P4502C19. Drug Metabolism Disposition, 24, 610–615.
   PubMedGoogle Scholar